 CAMBRIDGE, Mass., Oct. 13, 2021 GLOBE NEWSWIRE -- TCR2 Therapeutics Inc. Nasdaq: TCRR, a clinical-stage cell therapy company with a pipeline of novel T cell therapies for patients suffering from cancer, today announced that it will host a virtual RD Day for analysts and investors at 8:00a.m. ET on Wednesday, October 20, 2021. 